Advertisement

Ads Placeholder
Loading...

Sunshine Biopharma, Inc.

SBFM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.04
$-0.05(-5.02%)
U.S. Market opens in 0h 55m

Sunshine Biopharma, Inc. (SBFM) Stock Overview

Explore Sunshine Biopharma, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.1M
P/E Ratio-0.81
EPS (TTM)$5.31
ROE-0.25%
Fundamental Analysis

AI Price Forecasts

1 Month$0.41
3 Months$0.00
1 Year Target$0.00

SBFM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sunshine Biopharma, Inc. (SBFM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.85, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.81 and a market capitalization of 5.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.02%
5-Day Change
1.96%
1-Month Change
-8.77%
3-Month Change
-18.75%
6-Month Change
-32.03%
Year-to-Date (YTD) Change
-18.75%
1-Year Change
-43.48%
3-Year Change
-99.92%
5-Year Change
-99.99%
All-Time (Max) Change
-100.00%

Contact Information

https://www.sunshinebiopharma.com
514 426 6161
6500 Trans-Canada Highway, Pointe-Claire, QC, H9R 0A5

Company Facts

520 Employees
IPO DateFeb 15, 2022
CountryCA
Actively Trading

Frequently Asked Questions